We will be performing site maintenance on AAOS.org on February 8th from 7:00 PM – 9:00 PM CST which may cause sitewide downtime. We apologize for the inconvenience.

Frank B. Kelly, MD, (left) cochair of the AAOS Now PRP Forum, listens intently as Pietro Randelli, MD, (right) discusses the effects of PRP on chronic tendinopathy.


Published 7/1/2011
Kaye Daugherty; Mary Ann Porucznik

Treating tendons, bones, and cartilage with PRP

A report from the AAOS Now PRP Forum

Versions of platelet-rich plasma (PRP) have been used to treat everything from plantar fasciitis to rotator cuff repair. But its effects differ, depending on the musculoskeletal structure and the composition of the PRP itself. Understanding how PRP affects the healing processes of various musculoskeletal tissues is critical to determining the appropriate type of PRP for specific injuries.

The PRP Forum, sponsored by AAOS Now and held on Feb. 14, 2011, in San Diego, brought together approximately 50 of the most knowledgeable and experienced clinicians and researchers in the field of PRP therapy. This is the third in a series of articles reviewing the material presented and summarizing the results of the Forum.

PRP and chronic tendinopathy
The pathophysiology of tendinopathy—the term used to refer to chronic inflammation of the tendon (as distinguished from tendinitis, which refers to the acute inflammatory state)—remains elusive. Chronic tendinopathies include conditions such as Achilles tendinosis, lateral/medial epicondylitis, plantar fasciitis, patellar tendinopathy, and chronic rotator cuff injuries.

According to Pietro Randelli, MD, of the University of Milan, several studies have examined the effects of PRP on chronic tendinopathy, with mixed results. Although most of the published reports have been case studies, “four randomized controlled studies and two prospective comparative studies have been conducted, evaluating the treatment of chronic tendinopathy with PRP. Four of them were favorable to PRP,” he said.

James R. Andrews, MD, medical director of the American Sports Medicine Institute, in Birmingham, Ala., pointed out that the effectiveness of PRP in treating tendinosis has not been scientifically proven in human trials. Dr. Andrews recommended that PRP injections should be used in conjunction with other treatments, including rest, ice, anti-inflammatory medication, and physical therapy, in a multimodal plan to promote symptom relief and tendon healing.

PRP has been proposed to augment reconstruction of the anterior cruciate ligament (ACL) in two ways. At the midsubstance of the tendon, PRP appears to harbor ACL cell viability and function in vitro, leading to enhanced histologic repair. When used to enhance bone healing at the graft-bone interface, however, PRP did not demonstrate any clinical or biomechanical effects at a 2-year follow-up in a level 1 randomized clinical trial. Whether these findings are applicable to other ligaments in the knee (medial or lateral collateral ligaments) is not known.

PRP and bone healing
“PRP has been proposed as an alternative to autograft in a variety of spinal arthrodesis environments,” reported Wellington Hsu, MD, assistant professor in the departments of orthopaedic and neurologic surgery at the Northwestern University Feinberg School of Medicine. These include the posterolateral lumbar interbody, the anterior lumbar interbody, and the anterior cervical interbody fusions.

“But animal and clinical studies do not demonstrate any benefit with the use of PRP in augmenting spine fusion,” he said. “In fact, in some situations, PRP has been observed to inhibit bone formation.”

Although the mechanism of action for this is unclear, PRP may contain inhibitory factors that counteract the effects of the stimulatory growth factors also present in the concentrate.

Frank B. Kelly, MD, (left) cochair of the AAOS Now PRP Forum, listens intently as Pietro Randelli, MD, (right) discusses the effects of PRP on chronic tendinopathy.

In discussing the use of PRP in treating fractures, Dr. Hsu noted that some in vitro and animal studies suggest that PRP promotes new bone formation, and appears to be safe and feasible. But no clinical evidence supports PRP use in acute or delayed fracture healing.

PRP and cartilage defects
Platelets, noted Elizaveta Kon, MD, of the Rizzoli Orthopaedic Institute in Bologna, Italy, provide an autologous source of growth factors for healing and tissue regeneration. In addition, use of a platelet gel can be a positive influence in clinical situations that require rapid healing and tissue regeneration.

Studies of the use of PRP for cartilage degeneration have shown more consistently favorable results. The largest study (115 knees) found PRP injections effective at improving pain, function, and quality of life in patients with chondral injuries and early or advanced osteoarthritis, and a comparison of PRP and hyaluronan injections for osteoarthritis of the knee found improved scores with the use of PRP.

The problem, said Dr. Kon, is that different procedures for producing PRP yield different concentrates and different results. Although her own research has shown that intra-articular knee injections of PRP produced favorable results on degenerative cartilage lesions, she called for “better knowledge about how PRP affects healing, and more biologic and randomized clinical trials.”

Other uses
One of the early uses of PRP in orthopaedics was the addition of a PRP fibrin sealant added to total knee arthroplasties. Both a retrospective chart review and a comparative study have found less postoperative blood loss, less narcotic use, and earlier hospital discharge with the use of PRP. A recent laboratory study has confirmed that PRP exerts an antimicrobial action against both gram-negative and gram-positive bacteria.

To receive an electronic copy (PDF) of the Forum agenda book, including selected abstracts covering more than 30 studies on the efficacy of PRP, e-mail aaoscomm@aaos.org

Kay Daugherty is the medical editor for the Campbell Foundation. Mary Ann Porucznik is managing editor of AAOS Now.

About the PRP Forum
Cochaired by AAOS Now Editor-in-Chief S. Terry Canale, MD, and AAOS Now editorial board member Frank B. Kelly, MD, the PRP Forum, held on Feb. 14, 2011, in San Diego, featured a series of presentations, followed by break-out group discussions, resulting in a series of recommendations for future study of PRP.

Presenters included Steven P. Arnoczky, DVM; Freddie H. Fu, MD; Wellington Hsu, MD; Elizaveta Kon, MD; Allan K. Mishra, MD; Nicola Maffulli, MD, PhD; Pietro Randelli, MD; and Scott A. Rodeo, MD. Support for the PRP Forum was provided by unrestricted educational grants from Arteriocyte Medical Systems and Zimmer, Inc.


  1. Engebretsen L, Steffen K, Alsousou J, Anitua E, et al. IOC consensus paper on the use of platelet-rich plasma in sports medicine. Br J Sports Med. 2010 Dec;44(15):1072-81.
  2. Anitua E, Andia I, Sanchez M, Azofra J, del Mar Zalduendo M, et al. Autologous preparations rich in growth factors promote proliferation and induce VEGF and HGF production by human tendon cells in culture. J Orthop Res 2005; 23:281-6.
  3. Arnoczky SP, Anderson L, Fanelli G, Ho S, et al. The role of platelet-rich plasma in connective tissue repair. Orthopedics Today 2009; 26:29.
  4. Aspenberg P, Virchenko O. Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthop Scand 2004; 75:93-99.
  5. Barrett S, Erredge S. Growth factors for chronic plantar fasciitis. Podiatry Today 2004; 17:37-42.
  6. Carreon LY, Glassman SD, Anekstein Y, Puno RM. Platelet gel (AGF) fails to increase fusion rates in instrumented posterolateral fusion. Spine (Phila Pa 1976) 2005; 30:E243-6.
  7. Creaney L, Wallace A, Curtis M, Connell D. Growth factor-based therapies provide additional benefit beyond physical therapy in resistant elbow tendinopathy: a prospective, single-blind, randomized trial of autologous blood injections versus platelet-rich plasma injections. Br J Sports Med 2011 Mar 15 [Epub ahead of print].
  8. Dallari D, Savarino L, Stagni C, Cenni E, et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 2007; 89:2413-20.
  9. de Mos M, van der Windt AE, Jahr H, van Schie HT, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med 2008; 36:1171-8
  10. de Vos RJ, van Veldhoven PL, Moen MH, Weir A, et al. Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull 2010; 95:63-77.
  11. de Vos RJ, Weir A, Tol JL, Verhaar JA, et al. No effects of PRP on ultrasonographic tendon structure and neovascularization in chronic midportion Achilles tendinopathy. Br J Sports Med 2011; 45:387-92.
  12. de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, et al. Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 2010; 303:144-9.
  13. Gaweda K, Tarczynska M, Krzyzanowski W. Treatment of Achilles tendinopathy with platelet-rich plasma. Int J Sports Med 2010; 31:577-83.
  14. Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. Am J Sports Med 2011 Mar 21. [Epub ahead of print]
  15. Han B, Woodell-May J, Ponticiello M, Yang Z, Nimni M. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am 2009; 91:1459-70.
  16. Hechtman KS, Uribe JW, Botto-Vandemden A, Kiebzak GM. Platelet-rich plasma injection reduces pain in patients with recalcitrant epicondylitis. Orthopedics 2011; 34(2):92. OrthoSuperSite.com/view.aspx?rID=79478.
  17. Jenis LG, Banco RJ, Kwon B. A prospective study of autologous growth factors (AGF) in lumbar interbody fusion. Spine J 2006; 6:14-20.
  18. Lyras D, Kazakos K, Verettas D, Polychronidis A, Simopoulos C, Botaitis S, Agrogiannis G, Kokka A, Patsouris E. Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect. Int Orthop 2010; 34:143-8.
  19. Ma L, Zheng LW, Sham MH, Lam CK, Zwahlen RA, Cheung LK. Effect of plate-rich plasma on a rabbit model of nicotine-compromised bone healing. J Oral Maxillofac Surg 2011; 69:28-35.
  20. Menetrey J, Kasemkijwattana C, Day CS, Bosch P, et al. Growth factors improve muscle healing in vivo. J Bone Joint Surg Br 2000; 82:131-7.
  21. Mishra A, Collado H, Fredericson M. Platelet-rich plasma compared with corticosteroid injection for chronic lateral elbow tendinosis. PM R 2009; 1:366-70.
  22. Mishra A, Pavelko T. Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med 2006; 34:1774-8..
  23. Nin JR, Gasque GM, Azcárate AV, Beola JD, Gonzalez MH. Has platelet-rich plasma any role in anterior cruciate ligament allograft healing? Arthroscopy 2009; 25:1206-13.
  24. Orrego M, Larrain C, Rosales J, Valenzuela L, Matas J, Durruty J, Sudy H, Mardones R. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons ina bone tunnel. Arthroscopy 2008; 24:1373-80.
  25. Paoloni J, de Vos RJ, Hamilton B, Murrell GA, Orchard J. Platelet-rich plasma treatment for ligament and tendon injuries. Clin J Sports Med 2011; 21:37-45.
  26. Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with 1-year follow-up. Am J Sports Med 2010; 38:255-62.
  27. Peerbooms JC, van Laar W, Faber F, Schuller HM, van der Hoeven H, Gosens T. Use of platelet rich plasma to treat plantar fasciitis: design of a multi-centre randomized controlled trial. BMC Musculoskelet Disord 2010; 11:69.
  28. Rodeo SA, Delos D, Williams RJ 3rd, Adler R, Pearle AD, Warren RF. The effect of platelet-rich fibrin matrix on rotator cuff tendon healing: a prospective, randomized clinical study. AOSSM 2011 Specialty Day, San Diego CA, February 2011.
  29. Sanchez M, Anitua E, Andia I. Application of autologous growth factors on skeletal muscle healing. Second International Congress on Regnerative Medicine.
  30. Sanchez M, Anitua E, Azofra J, Andia I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007; 35:245-51.
  31. Sánchez M, Anitua E, Azofra J, Prado R, Muruzabal F, Andia I. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology. Arthroscopy 2010; 26:479-80.
  32. Savarino L, Cenni E, Tarabusi C, Dallari D, et al. Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standaridized methodology in patients with tibial osteotomy for genu varus. J Biomed Mater Res B Appl Biomater 2006; 76:364-72.
  33. Schepull T, Kvist J, Norrman H, Trinks M, Berlin G, Aspenberg P. Autologous platelets have no effect on the healing of human Achilles tendon ruptures: a randomized single-blind study. Am J Sports Med 2011; 39:38-47.
  34. Scholz M, Schleicher P, Eindorf T, Friedersdorff F, et al. Cages augmented with mineralized collagen and platelet-rich plasma as an osteoconductive/inductive combination for interbody fusion. Spine (Phila Pa 1976) 2010; 35:740-6.
  35. Shen W, Li Y, Zhu J, Huard J. Interaction between macrophages, TGF-beta1, and the COX-2 pathway during inflammatory phase of skeletal muscle healing after injury. J Cell Physiol 2008; 214:405-412.
  36. Silva A, Sampaio R. Anatomic ACL reconstruction: does the platelet-rich plasma accelerate tendon healing? Knee Surg Sports Traumatol Arthrosc 2009; 17:676-82.
  37. Tidball JG. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol 2005; 288:R345-53.
  38. Visser LC, Arnoczky SP, Caballero O, Kern A, et al. Growth factor-rich plasma increases tendon cell proliferation an dmatrix synthesis on a synthetic scaffold: an in vitro study. Tissue Eng Part A 2010; 16:1021-9.
  39. Vogrin M, Rupreht M, Dinevski D, Haspl M, et al. Effects of a platelet gel on early graft revascularization after anterior cruciate ligament reconstruction: a prospective, randomized, double-blind, clinical trial. Eur Surg Res 2010; 45:77-85.
  40. Weiner BK, Walker M. Efficacy of autologous growth factors in lumbar intertransverse fusions. Spine (Phila Pa 1976) 2003; 28:1968-70.